DekaBank Deutsche Girozentrale’s Roivant Sciences ROIV Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-350,000	Closed	-$4.13M	–	1312
2025 Q4	$4.13M	Hold	350,000	–	–	0.01%	619
2025 Q3	$5.22M	Hold	350,000	–	–	0.01%	567
2025 Q2	$3.96M	Hold	350,000	–	–	0.01%	615
2025 Q1	$3.58M	Hold	350,000	–	–	0.01%	628
2024 Q4	$3.93M	Hold	350,000	–	–	0.01%	625
2024 Q3	$3.83M	Hold	350,000	–	–	0.01%	638
2024 Q2	$3.54M	Hold	350,000	–	–	0.01%	650
2024 Q1	$3.59M	Hold	350,000	–	–	0.01%	651
2023 Q4	$3.81M	Hold	350,000	–	–	0.01%	638
2023 Q3	$3.96M	Hold	350,000	–	–	0.01%	588
2023 Q2	$3.32M	Buy	350,000 +50,000	+17%	+$447K	0.01%	647
2023 Q1	$2.09M	Buy	300,000 +100,000	+50%	+$823K	0.01%	713
2022 Q4	$1.5M	Buy	+200,000	New	+$1.11M	﹤0.01%	785

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

DekaBank Deutsche Girozentrale's ROIV Position: Q1 2026 in Review

DekaBank Deutsche Girozentrale sold out of Roivant Sciences (ROIV) in Q1 2026, closing a stake of 350,000 shares — an estimated $4.13M sold.

DekaBank Deutsche Girozentrale first reported a position in ROIV in Q4 2022 and held it in 13 quarters. The position peaked at $5.22M in Q3 2025. 444 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

DekaBank Deutsche Girozentrale reported no remaining Roivant Sciences position as of Q1 2026 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 350,000 Roivant Sciences shares in Q1 2026, an estimated $4.13M.
DekaBank Deutsche Girozentrale first reported a position in Roivant Sciences in Q4 2022 and held it in 13 quarters.
DekaBank Deutsche Girozentrale's Roivant Sciences position peaked at $5.22M in Q3 2025.
444 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.